





















Recently, the International Agency for Research on 
Cancer (IARC) concluded that  "shift-work that in-
volves circadian disruption is probably carcinogenic to 
humans" [1]. This conclusion was based upon limited 
evidence in humans [2, 3] and sufficient evidence in 
experimental animals [4, 5]. The current experimental 
results of Vinogradova and colleagues from 
Petrozavodsk and St. Petersburg render further support 
to this important issue and indicate a number of highly 
relevant points that will have to be taken into 
consideration for a better understanding of the 
mechanisms involved and possible extrapolations to the 
situation in humans. Their aim was see in which way 
constant bright light of 750 Lux (LL) may  affect 
survival and tumor development of normal outbred 
male and female rats of the LIO-strain in comparison to 
animals kept under a standard photoperiod of 
LD=12h:12h. LL was applied life-long starting from 
either 1 or 14 months of age. At one month of age 
animals are becoming sexually mature whereas at 14 
months sexual competence declines. The authors found 
that dramatic life-shortening effects are observed among 
female rats, particularly in those where LL-treatment 
was started at one month of age. They interpret these 
findings to indicate that constant light probably exerts 
its detrimental effects on health, tumorigenesis as well 
as survival via disturbances of the female reproductive 
cycle [6]. The mechanisms involved can be assumed to 
include the pineal hormone melatonin as well which as 
chemical signal of darkness and controlled by the 

























may play a very central part since it is suppressed by LL 
and participates in the neuroendocrine control of the 
female reproductive system. In addition, the authors 
present interesting data that disturbances in the 
regulation of the anti-oxidative enzymes superoxide-
dismutase and catalase due to LL are also involved. 
These enzymes are known to be controlled by melatonin 
due to its anti-oxidative action [8]. These fascinating 
results of the team led by V.N. Anisimov clearly show 
that for a better understanding of the highly relevant 
issue of shift-work but also of jet-lag and space-flight 
and other life-styles connected with circadian disruption 
[9-12] it will be important to specifically consider 
developmental aspects. It appears to be very clear that 
photoperiodic experiences early in life are essential 
determinants for carcinogenic processes to develop at 
higher age. An important question to be addressed by 
future experiments is whether there might be a critical 
period towards the negative effects of LL in and around 
early adulthood or whether circadian disturbances have 
to persist over a longer period of time throughout life to 
promote cancer. We have to be thankful to the authors 
that they have started to open our eyes to consider such 
basic and complex issues and it will have to be seen in 
which way these findings will be applicable to women 
who are increasingly afflicted by breast cancer. 
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